SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001140361-20-009838
Filing Date
2020-04-27
Accepted
2020-04-27 17:01:15
Documents
4

Document Format Files

Seq Description Document Type Size
1 F-1/A nt10009045x4_f1a.htm F-1/A 159999
2 EXHIBIT 10.17 nt10009045x4_ex10-17.htm EX-10.17 787182
3 EXHIBIT 10.18 nt10009045x4_ex10-18.htm EX-10.18 185593
4 EXHIBIT 10.19 nt10009045x4_ex10-19.htm EX-10.19 123137
  Complete submission text file 0001140361-20-009838.txt   1256898
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-237841 | Film No.: 20820957
SIC: 2834 Pharmaceutical Preparations